Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration
Clinical Pharmacokinetics · 2024-04 · 63 (4) · 483-496
DOI: 10.1007/s40262-024-01352-9 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Clinical Pharmacokinetics, online erschienen am 29.02.2024. Verfasst von Joseph Piscitelli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc, San Diego, CA, USA. Hauptthemen laut MEDLINE: Bupropion, Carbamates, Coproporphyrins, Drug Interactions. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pfizer Inc, San Diego, CA, USA.
- Pfizer Inc, Boulder, CO, USA.
- Pierre Fabre Medicament, Toulouse, France.
- Pfizer Inc, New York, NY, USA.
- Pfizer Inc, Groton, CT, USA.
- Pfizer Inc, Collegeville, PA, USA.
ORCID-Profile: Joseph Piscitelli
Förderung
- Pfizer
Zitieren
APA
Piscitelli, J., Reddy, M. B., Wollenberg, L., Del Frari, L., Gong, J., Wood, L., Zhang, Y., Matschke, K., & Williams, J. H. (2024). Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration. Clinical Pharmacokinetics, 63(4), 483-496. https://doi.org/10.1007/s40262-024-01352-9
Vancouver
Piscitelli J, Reddy MB, Wollenberg L, Del Frari L, Gong J, Wood L, et al. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration. Clinical Pharmacokinetics. 2024;63(4):483-496. doi:10.1007/s40262-024-01352-9
BibTeX
@article{Piscitelli2024,
author = {Piscitelli, Joseph and Reddy, Micaela B and Wollenberg, Lance and Del Frari, Laurence and Gong, Jason and Wood, Linda and Zhang, Yizhong and Matschke, Kyle and Williams, Jason H},
title = {Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration},
journal = {Clinical Pharmacokinetics},
year = {2024},
volume = {63},
number = {4},
pages = {483--496},
doi = {10.1007/s40262-024-01352-9}
}
EUVIMED